Dr. Ahmet Hoke is Professor of Neurology and Neuroscience, W. W. Smith Charitable Trust Professor of Neuroimmunology at Johns Hopkins School of Medicine, Director of the Daniel B. Drachman Division of Neuromuscular Diseases and Director of the Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins University School of Medicine. He completed his medical training at Hacettepe University School of Medicine in Ankara, Turkey followed by his PhD studies in developmental neuroscience at Case Western Reserve University in Cleveland, Ohio, and neurology residency at Johns Hopkins Hospital. After completing his neuromuscular training at University of Calgary, Canada, he returned to Johns Hopkins University as faculty and rose through the ranks. He is the recipient of several awards including Derek Denny Brown Young Neurological Scholar Award (2005) and Wolfe Neuropathy Research prize (2018) given by the American Neurological Association, Myung Memorial Lecture Award (2017) by the Korean Neurological Association, Nejat Eczacibasi Medical Scientist Award (2019) by the Eczacibasi Foundation, Turkey, and Alan J. Gebhart Prize in Excellence in Neuropathy Research (2022) by the Peripheral Nerve Society. He is an Ex-Officio member of the Board of Directors of the American Neurological Association, and Vice-President of the Toxic Neuropathy Consortium. He serves on several editorial boards and is the Editor-in-Chief of Annals of Clinical and Translational Neurology. Dr. Hoke is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Wallerian Degeneration, Peripheral Neuropathy, Tomaculous Neuropathy, Spinal Muscular Atrophy with Arthrogryposis, and Prostatectomy.

Dr. Peter Kaplan is Professor of Neurology and serves as the Director of Epilepsy and EEG at Johns Hopkins Bayview Medical Center. He focuses on epilepsy, clinical neurophysiology and nonconvulsive status epilepticus. He has written extensively about these subjects as well as about eclampsia and neurologic disease in women. Dr. Peter Kaplan received his medical training from St. Bartholomews Medical School, University of London. He then obtained membership to the Royal College of Physicians in England. He completed his residency in neurology at Duke University Medical Center. He completed fellowships in epilepsy and clinical neurophysiology at the same institution. Dr. Kaplan currently sees patients at the Johns Hopkins Bayview Medical Center on Tuesdays and Wednesdays. Dr. Kaplan is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Seizures, Generalized Tonic-Clonic Seizure, Status Epilepticus, Epilepsy, and Awake Craniotomy.

Dr. Probasco is a professor at the Johns Hopkins University School of Medicine Department of Neurology. He is the Vice Chair for Quality, Safety, and Service for the department. He also serves as the Director of the Johns Hopkins Division of Advanced Clinical Neurology as well as the Medical Director of the Johns Hopkins Inpatient General Neurology Service. He co-directs the Johns Hopkins Encephalitis Center and the Johns Hopkins Center for Refractory Status Epilepticus and Neuroinflammation. He cares for general neurology inpatients and outpatients, specializing in autoimmune and paraneoplastic syndromes as well as neurological immune-related adverse events following immunotherapies for cancer. After completing his undergraduate studies in biochemistry at the University of New Mexico, Dr. Probasco attended the University of Oxford as a Rhodes Scholar and earned a second undergraduate degree in psychology, philosophy and physiology. He went on to earn his medical degree at the University of California, San Francisco. He completed an internship in internal medicine at Johns Hopkins Bayview Medical Center and a residency in neurology at Johns Hopkins, where he was the faculty liaison/executive chief resident. He went on to complete an instructorship in inpatient general neurology at Johns Hopkins. Dr. Probasco’s research interests include increasing care value through improving outcomes, incorporation of patient experience of disease and treatment, the efficiency of care delivery, and diagnostic test utilization in general and specifically in relation to autoimmune and paraneoplastic neurological syndromes, including encephalitis. Finally, he is interested in the management of neurological immune-related adverse events following immunotherapies for the treatment of cancer. Dr. Probasco has been recognized at the departmental, institutional, and national levels for teaching and clinical excellence, including the American Academy of Neurology’s A.B. Baker Teacher Recognition Award and the Frank L. Coulson, Jr. Award from the Johns Hopkins Medicine Miller-Coulson Academy of Clinical Excellence. He is a past graduate of the Johns Hopkins Armstrong Institute Resident Scholars (AIRS) program in Patient Safety and Quality. As a faculty member, he was inducted into the Miller-Coulson Academy of Clinical Excellence in 2019. He serves as Editor-in-Chief of NEJM Journal Watch Neurology. Videos The impact of COVID-19 on the Department of Neurology‚Äôs clinical care and medical education programs. Dr. Probasco is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Encephalitis, Anti-NMDA Receptor Encephalitis, Status Epilepticus, Creutzfeldt-Jakob Disease, and Gastrostomy.

Brenda Banwell is the director of the Department of Pediatrics, as well as pediatrician-in-chief and co-director of Johns Hopkins Children’s Center, where she helps manage the hospital’s many clinical and research centers. Dr. Banwell is a renowned expert in the research and treatment of pediatric multiple sclerosis (MS) and other neuroimmune disorders. She specializes in and studies the use of neuroimaging to assess the clinical and cognitive impact of the conditions, as well as the function of the immune system in children with these disorders. She also created a standardized clinical care algorithm and clinical database in order to evaluate the clinical impact of MS. Dr. Banwell has published more than 250 manuscripts in high-impact journals, along with over 25 book chapters. In addition, she has over 200 national and international invited lectureships and visiting professorships. An advocate for pediatric multiple sclerosis needs and research, Dr. Banwell serves as chair of the International Medical and Scientific Board of the Multiple Sclerosis International Federation, and the Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD) International Research Consortium. She is also chair of the pediatric committee of the National Institutes of Health NeuroNEXT program, which conducts studies on treatments for neurological diseases through academic, private, and industry collaborations. Dr. Banwell currently serves as past-chair of the International Pediatric Multiple Sclerosis Study Group, Dr. Banwell earned her medical degree from the University of Western Ontario. She later completed a residency in pediatrics at the University of Western Ontario-Children's Hospital of Western Ontario and a second residency in pediatric neurology at University of Toronto – The Hospital for Sick Children. Her residencies were followed by a fellowship in neuromuscular research at Mayo Clinic. Dr. Banwell is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. Her top areas of expertise are Multiple Sclerosis (MS), CACH Syndrome, Optic Neuritis, and Transverse Myelitis.

Dr. Sun is an expert in both pediatric neurology and cerebrovascular neurology, with a special interest in pediatric and young adult stroke. She focuses on both acute care of stroke as well as longitudinal management of an array of neurologic conditions that affect children and young adults. Dr. Sun’s research focuses broadly on pediatric and young adult stroke, with emphasis on discovering the causes, treatments, and prevention of stroke in the young. More specifically, Dr. Sun is investigating novel monitoring and stroke prevention techniques in children with moyamoya disease, which is a rare disease that places affected children and young adults at high risk of stroke. The goal of Dr. Sun's research is to improve outcomes and quality of life of individuals affected by stroke and moyamoya disease. In addition to her clinical and research interests, Dr. Sun is the associate program director of the Child Neurology residency program at Johns Hopkins. After completing medical school at the Johns Hopkins University School of Medicine, Dr. Sun completed her pediatrics and neurology residency training at Johns Hopkins, and subsequently she completed a fellowship in Vascular Neurology/Stroke. Dr. Sun is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. Her top areas of expertise are Moyamoya Disease, Stroke, Stiff Person Syndrome, Thrombectomy, and Cerebral Artery Bypass Surgery.

Selvi Rajagopal, MD, MPH is a diplomat of the American Board of Obesity Medicine. She specializes in medical weight management to prevent and treat chronic disease beginning in late adolescence through adulthood. In her clinical practice at the Johns Hopkins Healthful Eating, Activity and Weight Program, she works with individuals to implement a holistic approach to achieve their health goals through sustainable weight loss and weight maintenance, incorporating key elements of nutrition, exercise, mental health and medication management. Beyond her clinical role, Dr. Rajagopal is engaged in medical student and resident education within Obesity Medicine. Her research and public health interests include the improvement of health and nutrition literacy and food environment policy reform as strategies to reduce chronic disease burden among low-income populations across the age spectrum. Dr. Rajagopal received her Doctor of Medicine degree from George Washington University School of Medicine in Washington, DC. She completed a combined training in Internal Medicine and Pediatrics at Baylor College of Medicine in Houston, Texas. Following residency, she worked as a Medicine-Pediatrics hospitalist prior to joining the combined General Preventive Medicine Residency-Masters in Public Health Program at the Johns Hopkins University Bloomberg School of Public Health in 2018 to pursue her interests in population health and chronic disease prevention. She pursued additional clinical training in weight management at the Johns Hopkins Digestive Weight Loss Center during her Preventive Medicine residency and has since joined clinical faculty within the Division of General Internal Medicine at the Johns Hopkins University School of Medicine. Dr. Rajagopal is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. Her top areas of expertise are Obesity, Sepsis, Neurotoxicity Syndromes, and Balloon Sinuplasty.

Merrill Ansher is a Neurologist in Columbia, Maryland. Dr. Ansher is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Seizures, Familial Neurocardiogenic Syncope, Delirium, and Generalized Tonic-Clonic Seizure.

Khalil Husari, M.D., is a neurologist with expertise in epilepsy, electroencephalography (EEG), and neurophysiology. He specializes in treating patients with seizures and epilepsy, presurgical evaluation for and the management of drug-resistant epilepsy, and the acute and chronic management of patients with status epilepticus. Additionally, he specializes in intraoperative neuromonitoring and is the director of the Intraoperative Neurophysiological Monitoring (IONM) Unit. Dr. Husari earned his medical degree from the University of Jordan School of Medicine, then completed his residency in neurology at the University of Texas Southwestern Medical Center, where he served as a chief resident during his final year. Dr. Husari continued his training as an epilepsy fellow at the Johns Hopkins University School of Medicine. Dr. Husari is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Seizures, Status Epilepticus, Epilepsy, Generalized Tonic-Clonic Seizure, and Osteotomy.

Peter Calabresi is a Neurologist in Baltimore, Maryland. Dr. Calabresi is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Multiple Sclerosis (MS), Optic Neuritis, Relapsing Multiple Sclerosis (RMS), and CACH Syndrome.

Kathryn Kelly is a primary care provider, practicing in Family Medicine in Silver Spring, Maryland. Dr. Kelly is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. Her top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, Gastrostomy, and Endoscopy.

Gaffar Syed is a primary care provider, practicing in Internal Medicine in Frederick, Maryland. Dr. Syed is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Ascites, COVID-19, Multisystem Inflammatory Syndrome in Children (MIS-C), Ureteroscopy, and Hip Replacement. Dr. Syed is currently accepting new patients.

Shannon Dean is a Neurologist and a Pediatric Neurologist in Baltimore, Maryland. Dr. Dean is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. Her top areas of expertise are Stereotypic Movement Disorder, Tourette Syndrome, Transient Tic Disorder, and Conversion Disorder.

Dr. George Ricaurte has a weekly clinic that focuses on Parkinsons disease and other movement disorders. In addition, he attends on the consult and in-patient neurology services at Johns Hopkins Bayview Medical Center. Dr. Ricaurte's research interests center on amphetamine-type stimulants and their potential to damage brain monoamine-containing neurons, including dopamine neurons (which degenerate in Parkinsons disease). Dr. Ricaurte and his colleagues are particularly interested in mechanisms of dopamine nerve cell degeneration. The long-term goal of this neurotoxicology research is to help find ways to prevent - or retard - the progression of Parkinsons disease and related neurodegenerative disorders. Dr. Ricaurtes work also has implications for the drug abuse field and substance abuse neuropsychiatric disorders. Dr. George Ricaurte received his medical degree from Northwestern University Medical School and his doctorate in Pharmacology from the University of Chicago. He then completed his residency in neurology at Stanford University Medical Center and did a one year fellowship at the Parkinsons Institute in California. Dr. Ricaurte is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Parkinson's Disease, Movement Disorders, Lewy Body Dementia (LBD), and Essential Tremor.

After completing her bachelors of science degree in biochemistry from the City College of New York (CUNY), Dr. Smith-Hicks entered the Medical Scientist Training Program at Columbia University College of Physicians and Surgeons, where she obtained her M.D., Ph.D. in 2000. She trained in Pediatrics at the Albert Einstein College of Medicine and completed her Neurology and Pediatric Neurology training at the Johns Hopkins University School of Medicine in 2005. Dr. Smith-Hicks trained as a post-doctoral fellow in the Department of Neuroscience at Johns Hopkins University School of Medicine under the guidance of Dr. Paul Worley. She joined the faculty at Kennedy Krieger Institute in 2010 where she now sees patients with Autism Spectrum Disorder and Rett Syndrome, while conducting basic science research exploring disorders of learning and memory. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. Her top areas of expertise are Rett Syndrome, Ruvalcaba Syndrome, Autism Spectrum Disorder, and Early Infantile Epileptic Encephalopathy.

David Cornblath is a Neurologist in Lutherville, Maryland. Dr. Cornblath is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Chronic Polyradiculoneuritis, Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, and Miller-Fisher Syndrome.

Ramaswamy Rangarajan is a primary care provider, practicing in Internal Medicine in Randallstown, Maryland. Dr. Rangarajan is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Multisystem Inflammatory Syndrome in Children (MIS-C), COVID-19, Dehydration, Gastrostomy, and Colonoscopy.

Avindra Nath is a Neurologist in Baltimore, Maryland. Dr. Nath is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Progressive Multifocal Leukoencephalopathy, Encephalitis, CACH Syndrome, and Stroke.

Andrew Goodwin is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Goodwin is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Sepsis, Acute Respiratory Distress Syndrome (ARDS), Common Cold, and Low Blood Pressure.

Robert Paschall is a Neurologist in Salisbury, Maryland. Dr. Paschall is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Epilepsy, Stroke, Memory Loss, Seizures, and Gastrostomy. Dr. Paschall is currently accepting new patients.

Lorenzo Leggio is a primary care provider, practicing in General Practice in Baltimore, Maryland. Dr. Leggio is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Delirium Tremens, Alcoholic Cirrhosis, Obesity, Liver Transplant, and Gastric Bypass.